New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
19:04 EDTTXI, VOXX, STJ, RT, QUIK, PSMTOn The Fly: After Hours Movers
UP AFTER EARNINGS: VOXX International (VOXX), up 16%... PriceSmart (PSMT), up 5.8%... DOWN AFTER EARNINGS/GUIDANCE: Ruby Tuesday (RT), down 8.6%... Texas Industries (TXI), down 8.6%... QuickLogic (QUIK), down 10.8% after lowering its Q4 revenue outlook... St. Jude Medical (STJ), down 3.4% after providing preliminary Q4 guidance.
News For VOXX;PSMT;RT;TXI;QUIK;STJ From The Last 14 Days
Check below for free stories on VOXX;PSMT;RT;TXI;QUIK;STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
April 9, 2014
16:10 EDTRTRuby Tuesday reports Q3 EPS ex-items (7c), consensus (8c)
Reports Q3 revenue $295.6M, consensus $284.22M. Reports Q3 SSS down 1.9% at company-owned restaurants.
16:05 EDTPSMTPriceSmart reports Q2 EPS 93c, consensus 88c
Subscribe for More Information
15:19 EDTPSMT, RTNotable companies reporting after market close
Subscribe for More Information
April 7, 2014
05:42 EDTTXIHolcim, Lafarge confirm intention to combine via merger of equals
Subscribe for More Information
April 6, 2014
14:38 EDTTXIEuropean cement makers Lafarge, Holcim approve $50B merger, WSJ says
Two of the world's largest cement makers, France's Lafarge (LFRGY) and Switzerland's Holcim agreed to a $50B merger, says the Wall Street Journal. The cement companies' boards met separately on Saturday and approved the deal, added the Wall Street Journal. Other names in the cement and buildings materials space include Vulcan Materials (VMC), Martin Marietta (MLM), Texas Industries (TXI), Eagle Materials (EXP) and CEMEX (CX). Reference Link
April 4, 2014
10:23 EDTTXICement names rise after report of industry giants exploring merger
Subscribe for More Information
08:08 EDTSTJSt. Jude Medical announces FDA approval of Protege IPG
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use